Quick Heal Technologies Ltd

Quick Heal Technologies Limited, pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, received a certificate from MUFG Intime India Private Limited, formerly known as Link Intime India Private Limited, confirming that no securities were received for dematerialization during the quarter ended September 30, 2026.

Quick Heal Technologies Limited notified the BSE Limited and National Stock Exchange of India Limited of the allotment of 2,431 equity shares under ESOP Scheme 2021 on October 1, 2026, increasing the total issued share capital to Rs 54,27,60,110 divided into 5,42,76,011 equity shares of Rs 10 each.

Quick Heal Technologies Limited will close its trading window for securities transactions from October 1, 2026, in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company’s code of conduct, and will reopen 48 hours after the declaration of un-audited financial results for the quarter ended September 30, 2026; the date of the board meeting to consider and approve the results will be announced separately.

Quick Heal Technologies Limited informed the Bombay Stock Exchange and National Stock Exchange of India that shareholders approved the re-appointment of Mr. Richard Stiennon as Non-Executive Independent Director for a second term of five years, effective September 27, 2026, to September 26, 2031, at the company's 31st Annual General Meeting on Wednesday, September 23, 2026.

Quick Heal Technologies Limited announced the allotment of 9,746 equity shares under its ESOP Scheme 2021 on September 3, 2026, increasing the total issued share capital to Rs 54,27,35,800 divided into 5,42,73,580 equity shares of Rs 10 each. The exercise price per share ranged from Rs 114 to Rs 122, with a premium of Rs 104 to Rs 112, and the shares will be credited to the company's permanent ISIN INE306L01010 upon final trading approval.

Quick Heal Technologies Limited announced the appointment of Mr. Amit Chaudhary as Vice President – Product Management, effective September 1, 2026, following a recommendation from the Nomination and Remuneration Committee. Prior to joining Quick Heal, Mr. Chaudhary served as Director, Technology Business at Cache Digitech Private Limited and previously spent more than two decades at Bharti Airtel, where he led the Cyber Security & Cloud business to Rs 600 crore in annual recurring revenue.

Quick Heal Technologies Limited announced the appointment of Mr. Rajiv Sreekantan as Senior Vice President - Enterprise Sales, effective August 11, 2026, following a recommendation from the Nomination and Remuneration Committee.

Quick Heal Technologies Limited informed the BSE Limited and National Stock Exchange of India Limited that Samuel Sathyajith, Senior Vice President - Enterprise Sales, has resigned from the company to pursue another professional opportunity, with his last working day on or before September 4, 2026.

Net Loss of Quick Heal Technologies reported to Rs 5.28 crore in the quarter ended June 2026 as against net loss of Rs 5.51 crore during the previous quarter ended June 2025. Sales declined 21.39% to Rs 44.99 crore in the quarter ended June 2026 as against Rs 57.23 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales44.9957.23 -21 OPM %-39.05-17.00 - PBDT-3.47-4.04 14 PBT-7.32-7.00 -5 NP-5.28-5.51 4 Powered by Capital Market - Live

Quick Heal Technologies will hold a meeting of the Board of Directors of the Company on 30 July 2026.